Abstract:Introduction: The endocannabinoids (eCBs), 2-arachidonoylglycerol (2-AG) and arachidonoyl ethanolamine (AEA), are produced by separate enzymatic pathways, activate cannabinoid (CB) receptors with distinct pharmacological profiles, and differentially regulate pathophysiological processes. The genetically encoded sensor, GRAB(eCB2.0), detects real-time changes in eCB levels in cells in culture and preclinical model systems; however, its activation by eCB analogues produced by cells and by phyto-CBs remains uncharacterized, a current limitation when interpreting changes in its response. This information could provide additional utility for the tool in in vivo pharmacology studies of phyto-CB action. Materials and Methods: GRAB(eCB2.0) was expressed in cultured HEK293 cells. Live cell confocal microscopy and high-throughput fluorescent signal measurements. Results: 2-AG increased GRAB(eCB2.0) fluorescent signal (EC50=85 nM), and the cannabinoid 1 receptor (CB1R) antagonist, SR141716 (SR1), decreased GRAB(eCB2.0) signal (IC50=3.3 nM), responses that mirror their known potencies at the CB1R. GRAB(eCB2.0) fluorescent signal also increased in response to AEA (EC50=815 nM), the eCB analogues 2-linoleoylglycerol and 2-oleoylglycerol (EC50=632 and 868 nM, respectively), Delta(9)-tetrahydrocannabinol (Delta(9)-THC), and Delta(8)-THC (EC50=1.6 and 2.0 mu M, respectively), and the artificial CB1R agonist, CP55,940 (CP; EC50=82 nM); however their potencies were less than what has been described at CB1R. Cannabidiol (CBD) did not affect basal GRAB(eCB2.0) fluorescent signal and yet reduced the 2-AG stimulated GRAB(eCB2.0) responses (IC50=9.7 nM). Conclusions: 2-AG and SR1 modulate the GRAB(eCB2.0) fluorescent signal with EC50 values that mirror their potencies at CB1R, whereas AEA, eCB analogues, THC, and CP increase GRAB(eCB2.0) fluorescent signal with EC50 values significantly lower than their potencies at CB1R. CBD reduces the 2-AG response without affecting basal signal, suggesting that GRAB(eCB2.0) retains the negative allosteric modulator (NAM) property of CBD at CB1R. This study describes the pharmacological profile of GRAB(eCB2.0) to improve interpretation of changes in fluorescent signal in response to a series of known eCBs and CB1R ligands.

Examining Changes in Gramicidin Current Induced by Endocannabinoids

Endocannabinoid regulation of inward rectifier potassium (Kir) channels

Modulation of the Cys-loop Ligand-Gated Ion Channels by Fatty Acid and Cannabinoids.

Actomyosin-mediated nanostructural remodeling of the presynaptic vesicle pool by cannabinoids induces long-term depression

Emerging mechanisms by which endocannabinoids and their derivatives modulate bacterial populations within the gut microbiome

Endocannabinoid Dynamics Gate Spike-Timing Dependent Depression and Potentiation

Differential Modulation of Nociceptive Versus Non-Nociceptive Synapses by Endocannabinoids.

Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor

Receptor-Dependent and Independent Regulation of Voltage-Gated Ca2+ Channels and Ca2+-Permeable Channels by Endocannabinoids in the Brain

Lights on Endocannabinoid-Mediated Synaptic Potentiation.

Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system

Membrane Cholesterol Dependence of Cannabinoid Modulation of Glycine Receptor

Pharmacological Characterization of the Endocannabinoid Sensor GRABeCB2.0

In Vivo Endocannabinoid Dynamics at the Timescale of Physiological and Pathological Neural Activity.

P2X7 receptor‐dependent increase in endocannabinoid 2‐arachidonoyl glycerol production by neuronal cells in culture: Dynamics and mechanism

Electrophysiological study of the interactive role of the cannabinoid breakdown inhibitors and L-type calcium channels on granular neurons in the hippocampal dentate gyrus in rats

A Common Molecular Basis For Exogenous And Endogenous Cannabinoid Potentiation Of Glycine Receptors (April, Pg 5200, 2012)

Cannabinoids and the Gastrointestinal Tract

New Insights in Cannabinoid Receptor Structure and Signaling

Influence of a Transmembrane Protein on the Permeability of Small Molecules Across Lipid Membranes

Modulation of Tonic GABA Currents by Anion Channel and Connexin Hemichannel Antagonists